NephroGenex
204 Cherwell Drive
Cary
North Carolina
27513
United States
Tel: 919-678-9512
Website: http://www.nephrogenex.com/
Email: info@nephrogenex.com
50 articles about NephroGenex
-
Biotech Bankruptcies Skyrocket
12/22/2023
From Statera Biopharma and Sorrento Therapeutics to Aceragen and Infinity Pharmaceuticals, 2023 has seen a record high 28 bankruptcies in the biotech space so far. Here’s why. -
North Carolina's NephroGenex Files for Chapter 11 and Seeks Sale
5/2/2016
-
NephroGenex, Under Threat of Being Delisted from the NASDAQ, Fires CEO and CSO
4/14/2016
-
NephroGenex Halts Clinical Program of Lead Drug, Will Take Time to Restructure and Go Over Strategic Alternatives
2/24/2016
-
NephroGenex To Host Conference Call And Webcast On Fourth Quarter And Full Year 2015 Financial Results On Thursday, February 25, 2016
2/16/2016
-
NephroGenex To Present At The 18th Annual BIO CEO & Investor Conference
1/27/2016
-
NephroGenex Announces Independent DSMB Recommendation To Continue Phase 3 Study Of Oral Pyridorin In Diabetic Nephropathy Without Modification
1/22/2016
-
NephroGenex To Participate In Two Healthcare Conferences In January
1/6/2016
-
NephroGenex Announces Formation Of Scientific Advisory Board
1/5/2016
-
NephroGenex Announces FDA Clearance Of IND Application For Clinical Study Of Intravenous Pyridorin In The Treatment Of Acute Kidney Injury
12/14/2015
-
NephroGenex Reports Third Quarter 2015 Financial Results
11/12/2015
-
NephroGenex Announces Successful Results From Toxicity Study Of Intravenous Pyridorin
11/5/2015
-
NephroGenex To Host Conference Call And Webcast On Third Quarter 2015 Financial Results On Thursday, November 12, 2015
11/4/2015
-
NephroGenex Announces $5.5 Million Private Placement
11/3/2015
-
NephroGenex To Present At The 2015 Aegis Growth Conference
9/30/2015
-
NephroGenex To Participate In Two Healthcare Conferences In September
8/31/2015
-
NephroGenex Reports Second Quarter 2015 Financial Results
8/13/2015
-
NephroGenex To Host Conference Call And Webcast On Second Quarter 2015 Financial Results On Thursday, August 13, 2015
8/7/2015
-
NephroGenex Announces Closing Of Public Offering Of Common Stock And Warrants
7/23/2015
-
NephroGenex Prices $7,500,000 Public Offering
7/17/2015